Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma

Published:2018-05-17 Issue:4 Volume:32 Page:974-981
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Duan Chongling¹,Li Yanxiang²,Yang Weifei³,Zhang Chao¹

Affiliation:

1. The Laboratory Center for Basic Medicine and Biomedical Isotope Research Center, School of Basic Medical Science, Shandong University, Jinan, P.R. China

2. Department of Urology, Qilu Hospital of Shandong University, Jinan, P.R. China

3. Department of Radiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, P.R. China

Funder

Natural Science Foundation of Shandong Province

Science and Technology Project of Shandong, China

Publisher

Informa UK Limited

Subject

Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2018.1475254

Reference32 articles.

1. Viral hepatitis and hepatocellular carcinoma: etiology and management

2. miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5-fluorouracil by targeting EIF4E

3. Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

4. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells

5. Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma;Molecular and Cellular Biochemistry;2022-06-16

2. Delivery of radioimmunotherapy for solid tumors;Systemic Drug Delivery Strategies;2022

3. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy;International Journal of Molecular Sciences;2018-12-05